PHARMACOKINETICS OF THE ENANTIOMERS OF FELODIPINE IN THE DOG AFTER ORAL AND INTRAVENOUS ADMINISTRATION OF A PSEUDORACEMIC MIXTURE

被引:17
作者
ERIKSSON, UG [1 ]
HOFFMANN, KJ [1 ]
SIMONSSON, R [1 ]
REGARDH, CG [1 ]
机构
[1] AB HASSLE,DEPT ORGAN CHEM,CARDIOVASC GRP,S-43183 MOLNDAL,SWEDEN
关键词
D O I
10.3109/00498259109039452
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. A pseudoracemic mixture of deuterated (S)-felodipine and unlabelled (R)-felodipine was administered as single i.v. or oral doses to four dogs. Plasma concentrations of the enantiomers and their corresponding pyridine metabolites were determined by g.l.c.-mass spectrometry. 2. No isotope effects were observed after oral administration of equimolar amounts of deuterated and unlabelled (S)-felodipine. 3. The pharmacokinetic parameters of the enantiomers were similar after i.v. administration, indicating that the disposition of felodipine was not stereoselective. 4. After oral administration the bioavailability of (R)-felodipine was slightly higher than that of (S)-felodipine in two of the dogs, presumably due to a lower first-pass extraction of the (R)-enantiomer, while no difference was observed in the other two dogs. 5. No substantial differences in C(max) or AUC were observed between the deuterated and unlabelled pyridine metabolites, indicating that the oxidative clearances of the felodipine enantiomers were similar.
引用
收藏
页码:75 / 84
页数:10
相关论文
共 33 条
[1]   COMPARISON OF HIGH-SELECTIVITY GAS-CHROMATOGRAPHIC METHODS, INCLUDING COLUMN SWITCHING, FOR THE DETERMINATION OF FELODIPINE IN PLASMA [J].
AHNOFF, M ;
ERVIK, M ;
JOHANSSON, L .
JOURNAL OF CHROMATOGRAPHY, 1987, 394 (03) :419-427
[2]   BIAS IN PHARMACOKINETICS AND CLINICAL-PHARMACOLOGY [J].
ARIENS, EJ ;
WUIS, EW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (04) :361-363
[3]   STEREOCHEMISTRY, A BASIS FOR SOPHISTICATED NONSENSE IN PHARMACOKINETICS AND CLINICAL-PHARMACOLOGY [J].
ARIENS, EJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (06) :663-668
[4]  
BAARNHIELM C, 1986, ACTA PHARMACOL TOX, V59, P113
[5]  
BAARNHIELM C, 1986, DRUG METAB DISPOS, V14, P613
[6]  
BAARNHIELM C, 1984, XENOBIOTICA, V14, P719
[7]  
COLLSTE P, 1985, DRUGS S2, V29, P117
[8]   THE FDA PERSPECTIVE ON THE DEVELOPMENT OF STEREOISOMERS [J].
DECAMP, WH .
CHIRALITY, 1989, 1 (01) :2-6
[10]   PHARMACOKINETICS OF FELODIPINE IN PATIENTS WITH IMPAIRED RENAL-FUNCTION [J].
EDGAR, B ;
REGARDH, CG ;
ATTMAN, PO ;
AURELL, M ;
HERLITZ, H ;
JOHNSSON, G .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (01) :67-74